Evidence map›Paper›PMID 32462531›Full record

ArticleRadiological physics and technology2020

Clinical significance of gadobutrol in magnetic resonance imaging for the detection of myocardial infarction: matched-pair cohort study to compare with gadopentetate dimeglumine at standard dose.

Kohei Kawasaki, Takumi Okubo, Tsutomu Nagatari, Masanobu Matsumoto, Takahiro Kageyama

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Radiological physics and technology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Kohei KawasakiDepartment of Radiology, Chiba Cerebral and Cardiovascular Center, 575 Tsurumai, Ichihara, Chiba, 290-0512, Japan. k.kwsk23@pref.chiba.lg.jp.
Takumi OkuboDepartment of Radiology, Chiba Cancer Center, 666-2 Nitonacyo Cyuo, Chiba, 260-8717, Japan.
Tsutomu NagatariDepartment of Radiology, Chiba Cerebral and Cardiovascular Center, 575 Tsurumai, Ichihara, Chiba, 290-0512, Japan.
Masanobu MatsumotoDepartment of Radiology, Chiba Cerebral and Cardiovascular Center, 575 Tsurumai, Ichihara, Chiba, 290-0512, Japan.
Takahiro KageyamaDepartment of Radiology, Chiba Cerebral and Cardiovascular Center, 575 Tsurumai, Ichihara, Chiba, 290-0512, Japan.
Chiba Cerebral and Cardiovascular Center · JPChiba Cancer Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We aimed to confirm whether gadobutrol is more useful for late gadolinium enhancement (LGE) imaging than gadopentetate dimeglumine (Gd-DTPA) at the standard dose. Patients who underwent LGE imaging to assess myocardial infarction were retrospectively enrolled: gadobutrol, 51 cases; Gd-DTPA, 49 cases. Contrast ratios of infarcted lesion to remote myocardium (CR

Indexed as

Contrast MediaGadolinium DTPAOrganometallic CompoundsCohort StudiesFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedMyocardial InfarctionContrast MediagadobutrolGadolinium DTPAOrganometallic CompoundsCardiac magnetic resonanceGadobutrolLate gadolinium enhancement imagingMatched-pair cohort studyMyocardial infarctionStandard dose

Identifiers

PMID32462531
OpenAlexW3030275381

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.